Search
Switzerland Approves Novartis' Groundbreaking Malaria Drug for Infants and Young Children
2025-07-08 /
Read about 0 minute
Author：小编
Novartis' Coartem Baby, a pioneering malaria treatment specifically tailored for newborns and infants, has secured approval in Switzerland. It is anticipated to swiftly gain authorization in eight participating African nations involved in the evaluation process. This medication addresses a critical gap in malaria treatment options for infants weighing under 4.5 kg.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
